JP2024525669A5 - - Google Patents

Info

Publication number
JP2024525669A5
JP2024525669A5 JP2024501194A JP2024501194A JP2024525669A5 JP 2024525669 A5 JP2024525669 A5 JP 2024525669A5 JP 2024501194 A JP2024501194 A JP 2024501194A JP 2024501194 A JP2024501194 A JP 2024501194A JP 2024525669 A5 JP2024525669 A5 JP 2024525669A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
variant
pharmaceutical composition
acid substitution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024501194A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024525669A (ja
JP7839260B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/069450 external-priority patent/WO2023284947A1/en
Publication of JP2024525669A publication Critical patent/JP2024525669A/ja
Publication of JP2024525669A5 publication Critical patent/JP2024525669A5/ja
Application granted granted Critical
Publication of JP7839260B2 publication Critical patent/JP7839260B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024501194A 2021-07-13 2021-07-13 糖尿病性腎症の処置のためのil1ra由来ペプチド Active JP7839260B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2021/069450 WO2023284947A1 (en) 2021-07-13 2021-07-13 Il1ra derived peptides for treatment of diabetic nephropathy

Publications (3)

Publication Number Publication Date
JP2024525669A JP2024525669A (ja) 2024-07-12
JP2024525669A5 true JP2024525669A5 (cg-RX-API-DMAC7.html) 2024-07-23
JP7839260B2 JP7839260B2 (ja) 2026-04-01

Family

ID=76958978

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024501194A Active JP7839260B2 (ja) 2021-07-13 2021-07-13 糖尿病性腎症の処置のためのil1ra由来ペプチド

Country Status (8)

Country Link
US (1) US20240216464A1 (cg-RX-API-DMAC7.html)
EP (1) EP4351617B1 (cg-RX-API-DMAC7.html)
JP (1) JP7839260B2 (cg-RX-API-DMAC7.html)
CN (1) CN117642174A (cg-RX-API-DMAC7.html)
AU (1) AU2021455992A1 (cg-RX-API-DMAC7.html)
CA (1) CA3226176A1 (cg-RX-API-DMAC7.html)
ES (1) ES3026437T3 (cg-RX-API-DMAC7.html)
WO (1) WO2023284947A1 (cg-RX-API-DMAC7.html)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
MXPA05002514A (es) * 2002-09-06 2005-05-27 Amgen Inc Anticuerpo monoclonal anti-il-1r1 humano terapeutico.
EP2686431B1 (en) 2011-03-14 2016-08-03 Phlogo ApS Antagonists of the interleukin- 1 receptor
WO2017063657A1 (en) 2015-10-14 2017-04-20 Phlogo Aps Il1ra-derived peptide antagonist
US10041044B2 (en) * 2016-07-29 2018-08-07 Trustees Of Boston University Age-associated clonal hematopoiesis accelerates cardio-metabolic disease development

Similar Documents

Publication Publication Date Title
JP2013515057A5 (cg-RX-API-DMAC7.html)
JP2012176978A5 (cg-RX-API-DMAC7.html)
JP2013515055A5 (cg-RX-API-DMAC7.html)
JP2023544834A5 (cg-RX-API-DMAC7.html)
JP2005516885A5 (cg-RX-API-DMAC7.html)
JP2008536483A5 (cg-RX-API-DMAC7.html)
JP2008540565A5 (cg-RX-API-DMAC7.html)
HRP20140616T1 (hr) Peptidni analog oksintomodulina
JP2021073174A5 (cg-RX-API-DMAC7.html)
US9518093B2 (en) Topical formulation of arginine-rich cyclic antimicrobial peptides
JP2023528204A5 (cg-RX-API-DMAC7.html)
IL240686A (en) Preparations containing cyclic peptides containing adjacent arginine residues
JP2020507623A5 (cg-RX-API-DMAC7.html)
JP2019533722A5 (cg-RX-API-DMAC7.html)
JPWO2019156137A5 (cg-RX-API-DMAC7.html)
JP2007535910A5 (cg-RX-API-DMAC7.html)
JP2023528207A5 (cg-RX-API-DMAC7.html)
JP2020172505A5 (cg-RX-API-DMAC7.html)
JP2024528407A5 (cg-RX-API-DMAC7.html)
JP2020117504A5 (cg-RX-API-DMAC7.html)
JP2025521082A5 (cg-RX-API-DMAC7.html)
JP2009534451A5 (cg-RX-API-DMAC7.html)
JP2008521795A5 (cg-RX-API-DMAC7.html)
JP2019526261A5 (cg-RX-API-DMAC7.html)
JP2014519514A5 (cg-RX-API-DMAC7.html)